Detailed introduction to the dosage of Nilotinib capsule form
Nilotinib is an oral tyrosine kinase inhibitor mainly used to treat patients with chronic myelogenous leukemia (CML). It is available in capsule form for patients to self-administer. Nilotinib capsules must be administered in strict accordance with the doctor's instructions to ensure drug efficacy and reduce the occurrence of side effects. Generally, nilotinib capsules are recommended to be taken twice daily at 300 mg each time or the dose may be adjusted according to specific conditions.
Nilotinib capsules should be taken on an empty stomach, preferably at least one hour before or two hours after a meal. Taking the drug on an empty stomach can help improve the absorption rate and bioavailability of the drug and ensure that the blood drug concentration is maintained within the effective range. In addition, patients should avoid taking foods or drugs containing high fat at the same time, so as not to affect the absorption and metabolism of nilotinib, resulting in reduced efficacy or increased toxicity.
During the medication process, patients need to strictly abide by the twice-daily taking time, keep the dosage even, and avoid missing doses or adjusting the dosage by themselves. If you accidentally miss a dose, you should take it as soon as possible when you discover it. However, if it is close to the next dose, you should skip the missed dose and continue taking it at the normal time. You should not take a double dose at one time to make up for the missed dose.
At the same time, when taking nilotinib, you should be careful not to take it with certain drugs, especially drugs that affect the liver metabolic enzymeCYP3A4, such as certain antifungals, antibiotics and anti-epileptic drugs, so as not to affect the blood concentration of nilotinib and increase the risk of adverse reactions. Patients need to regularly monitor blood indicators and electrocardiogram during the medication period to ensure the safety and efficacy of the medication. If they encounter any abnormal symptoms, they should contact their doctor in time.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)